Target intelligence / Profile preview

RNA, U6 small nuclear 546, pseudogene (RNU6-546P)

Target
RNU6-546P
Molecular classification
Other, Pseudogene, Derived from snRNA family (U6)
01

Overview

RNU6-546P (RNA, U6 small nuclear 546, pseudogene) is a classified pseudogene in the human genome and is not translated into a functional RNA or protein. It is derived from the U6 snRNA family, specifically mirroring the RNA sequence involved in the core spliceosomal complex responsible for pre-mRNA intron excision in eukaryotes. Pseudogenes like RNU6-546P are usually the result of gene duplication or retrotransposition events and do not produce the small U6 snRNA that participates in spliceosome catalytic activity. The presence of many U6-derived pseudogenes across the genome illustrates evolutionary redundancy, but these copies lack biological activity and are not implicated in disease, signal transduction, or as drug targets. Only the functional U6 snRNA (not pseudogenes) is directly involved in pre-mRNA splicing within the nucleus. Summary clarification: RNU6-546P is not a therapeutic target, has no disease relevance or drug interaction, functions solely as genomic redundancy, and is accurately described as a pseudogene derived from the U6 small nuclear RNA family.

Other names
RNU6-546P
02

Biological functions

None specific—pseudogenes generally do not have active biological functions, though some pseudogenes may exert minor regulatory functions by acting as competitive endogenous RNA or influencing chromatin structure. For RNU6-546P, no explicit function is reported.
03

Disease associations

None specific—no established role in disease is reported for RNU6-546P. Most U6-derived pseudogenes are “back-ups” and contribute to genomic redundancy but not to pathology or therapeutics.

Beyond the preview

Go deeper on RNA, U6 small nuclear 546, pseudogene (RNU6-546P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, U6 small nuclear 546, pseudogene (RNU6-546P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call